Effect of Ergocalciferol on β-Cell Function in New-Onset Type 1 Diabetes A Secondary Analysis of a Randomized Clinical Trial

被引：0
|
作者：
Nwosu, Benjamin Udoka [1 ,2 ]
Parajuli, Sadichchha [2 ,3 ]
Sharma, Rohit B. [4 ]
Lee, Austin F. [5 ]
机构：
[1] Northwell Hlth, Cohen Childrens Med Ctr, Dept Pediat, Div Endocrinol, New Hyde Pk, NY USA
[2] Univ Massachusetts, Sch Med, Dept Pediat, Div Endocrinol, Worcester, MA USA
[3] Louisiana State Univ Hosp, Monroe Family Med Program, Shreveport, LA USA
[4] Weill Cornell Med, Div Endocrinol Diabet & Metab, Dept Med, New York, NY USA
[5] Univ Massachusetts, Chan Med Sch, Dept Populat & Quantitat Hlth Sci, Worcester, MA 01605 USA
来源：
JAMA NETWORK OPEN | 2024年 / 7卷 / 03期
关键词：
D O I：
10.1001/jamanetworkopen.2024.1155
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This secondary analysis of a randomized clinical trial evaluates the effectiveness of ergocalciferol vs placebo in youths with newly diagnosed type 1 diabetes.
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Effect of Cholecalciferol as Adjunctive Therapy With Insulin on Protective Immunologic Profile and Decline of Residual β-Cell Function in New-Onset Type 1 Diabetes Mellitus
    Gabbay, Monica A. L.
    Sato, Maria N.
    Finazzo, Claudia
    Duarte, Alberto J. S.
    Dib, Sergio A.
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2012, 166 (07): : 601 - 607
  • [32] Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus - A randomized clinical trial
    Treiber, Genies
    Prietl, Barbara
    Froehlich-Reiterer, Elke
    Lechner, Evelyne
    Ribitsch, Anja
    Fritsch, Maria
    Rami-Merhar, Birgit
    Steigleder-Schweiger, Claudia
    Graninger, Winfried
    Borkenstein, Martin
    Pieber, Thomas R.
    CLINICAL IMMUNOLOGY, 2015, 161 (02) : 217 - 224
  • [33] The prevention of diabetes progression trial (PDPT):: Preservation of β-cell function using Daclizumab in new onset type 1 diabetes
    Rodriguez, H
    Amstutz, L
    Book, B
    Pescovitz, O
    Saha, C
    Sidner, R
    Pescovitz, M
    DIABETES, 2003, 52 : A44 - A44
  • [34] Classification of a Clinical Responder for Evaluation of Treatment Efficacy in Trials of New-Onset Type 1 Diabetes
    McGee, Paula L.
    Krause-Steinrauf, Heidi
    Greenbaum, Carla
    Pescovitz, Mark
    Herold, Kevan
    Spain, Lisa
    Palmer, Jerry
    Skyler, Jay
    Lachin, John M.
    DIABETES, 2011, 60 : A121 - A121
  • [35] Mycophenolate Mofetil and New-Onset Systemic Lupus Erythematosus: A Randomized Clinical Trial
    You, Yijun
    Zhou, Zhuochao
    Wang, Fan
    Li, Jian
    Liu, Honglei
    Cheng, Xiaobing
    Su, Yutong
    Chen, Xiaowei
    Zheng, Hui
    Sun, Yue
    Shi, Hui
    Hu, Qiongyi
    Xu, Jing
    Teng, Jialin
    Yang, Chengde
    Ye, Junna
    JAMA NETWORK OPEN, 2024, 7 (09)
  • [36] Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients
    Rigby, Mark R.
    Harris, Kristina M.
    Pinckney, Ashley
    DiMeglio, Linda A.
    Rendell, Marc S.
    Felner, Eric I.
    Dostou, Jean M.
    Gitelman, Stephen E.
    Griffin, Kurt J.
    Tsalikian, Eva
    Gottlieb, Peter A.
    Greenbaum, Carla J.
    Sherry, Nicole A.
    Moore, Wayne V.
    Monzavi, Roshanak
    Willi, Steven M.
    Raskin, Philip
    Keyes-Elstein, Lynette
    Long, S. Alice
    Kanaparthi, Sai
    Lim, Noha
    Phippard, Deborah
    Soppe, Carol L.
    Fitzgibbon, Margret L.
    McNamara, James
    Nepom, Gerald T.
    Ehlers, Mario R.
    JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (08): : 3285 - 3296
  • [37] A predictive model for lack of partial clinical remission in new-onset pediatric type 1 diabetes
    Marino, Katherine R.
    Lundberg, Rachel L.
    Jasrotia, Aastha
    Maranda, Louise S.
    Thompson, Michael J.
    Barton, Bruce A.
    Alonso, Laura C.
    Nwosu, Benjamin Udoka
    PLOS ONE, 2017, 12 (05):
  • [38] Empagliflozin And GABA Improve β-Cell Mass And Glucose Tolerance In New-Onset Type 1 Diabetes
    Daems, Caroline
    Welsch, Sophie
    Boughaleb, Hasnae
    Vanderroost, Juliette
    Robert, Annie
    Sokal, Etienne
    Lysy, Philippe
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 121 - 121
  • [39] Proinsulin peptide immunotherapy in type 1 diabetes: safety data of a first in new-onset type 1 diabetes phase 1b trial
    Ali, M. Alhadj
    Liu, Y-F.
    Stenson, R.
    Clifford, G.
    Adams, L.
    Powrie, J.
    Kyne, D.
    Leech, N.
    Green, K.
    Andrews, R.
    Peakman, M.
    Dayan, C.
    DIABETOLOGIA, 2015, 58 : S248 - S248
  • [40] Early retinal changes in children with new-onset type 1 diabetes
    Pilotto, Elisabetta
    Torresin, Tommaso
    Coppola, Marco
    Doblas, Joaquin
    Moretti, Carlo
    Midena, Edoardo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
12345